No-reflow phenomenon myocardial contrast echocardiography
No-reflow phenomenon Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
No-reflow phenomenon myocardial contrast echocardiography On the Web |
American Roentgen Ray Society Images of No-reflow phenomenon myocardial contrast echocardiography |
FDA on No-reflow phenomenon myocardial contrast echocardiography |
CDC onNo-reflow phenomenon myocardial contrast echocardiography |
No-reflow phenomenon myocardial contrast echocardiography in the news |
Blogs on No-reflow phenomenon myocardial contrast echocardiography |
Risk calculators and risk factors for No-reflow phenomenon myocardial contrast echocardiography |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Jennifer Giuseffi, M.D.; David M. Leder, M.D.; Ayokunle Olubaniyi, M.B,B.S [2]
Overview
This is the gold standard technique for investigating no-reflow phenomenon. This involves the use of intravascular contrast agents that contain tracers. This modality can be used to assess microvascular perfusion. It has the advantage of defining the extent of myocardium affected and also producing a good prognostic value which correllates with the TMPG.[1]
References
- ↑ Ito, H.; Maruyama, A.; Iwakura, K.; Takiuchi, S.; Masuyama, T.; Hori, M.; Higashino, Y.; Fujii, K.; Minamino, T. (1996). "Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction". Circulation. 93 (2): 223–8. PMID 8548892. Unknown parameter
|month=
ignored (help)